Researchers from the University of Leicester, working with international collaborators, have unraveled a key mechanism by ...

The accepted mechanism responsible for the cholesterol-lowering effect of probiotics is the inhibition of intestinal cholesterol ... such as the NPC1L1 protein, 3-hydroxy-3-methylglutaryl-CoA ...

Cite this: The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level - Medscape - Jan 01, 2003.

Ezetimibe is the only currently FDA-approved approved member of the of intestinal ... the Niemann-Pick C1-Like 1 (NPC1L1) receptor, which mediates the absorption of cholesterol from the small ...